Prosus N.V. (PRX)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 33.93 |
|---|---|
| 52-week range | 33.32 – 63.94 |
| Return, 1 month / 3 months | −9.7% / −8.6% |
| Return, 1 year / 3 years | −41.4% / +31.4% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 34.4% |
| Worst drawdown (1 year) | -45.4% |
| Average daily value traded | 107.00M EUR |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Prosus is an internet holding company based in the Netherlands that owns and operates consumer internet businesses around the world. Its activities span online classifieds, food delivery, payments and fintech, and education technology, run through subsidiaries and investments in various countries. It also holds a substantial stake in the Chinese technology group Tencent. The company backs and builds digital platforms that connect consumers with goods, services and financial tools across many markets.
Prosus N.V. trades under the code PRX on the Euronext Amsterdam in Netherlands, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Prosus N.V. (PRX) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 33.93 on 22 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 83 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.4% and over the last three months it fell 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.3% | ||
| From 52-week high | -45.4% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.6% | ||
| 6-month return | -20.0% | ||
| 12-month return, skipping the last month | -35.2% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.4% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 107.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.6% |
|---|---|
| 1 month | −9.7% |
| 3 months | −8.6% |
| 6 months | −20.0% |
| 1 year | −41.4% |
| 3 years | +31.4% |
| 5 years | −5.0% |
Signals
| 50-day / 200-day average | 36.30 / 40.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Nov 2026 | EUR 0.2800 |
| 31 Oct 2025 | EUR 0.2000 |
| 31 Oct 2024 | EUR 0.1000 |
| 2 Nov 2023 | EUR 0.0700 |
| 1 Sep 2022 | EUR 0.1400 |
| 28 Oct 2021 | EUR 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.